AstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
1 report, 1 independent
Updated Oct 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
European Society for Medical Oncology
Professional organisation
Related events
- AbbVie presented clinical data at the European Society for Medical Oncology (ESMO) Congress held in Madrid.
- Bristol-Myers Squibb presented clinical data at the European Society for Medical Oncology (ESMO) Congress in Madrid.
- Study results were presented by Tempus and Pfizer at the ESMO Congress, focusing on ongoing collaboration regarding diagnostic barriers.
- Hengrui Pharma and Guangdong Provincial People's Hospital presented research findings at the ESMO Congress on October 20, 2026.
- ORIC Pharmaceuticals presented clinical trial data at a medical oncology meeting.